Compare CRL & HBM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRL | HBM |
|---|---|---|
| Founded | 1947 | 1927 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Metal Mining |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.6B | 9.9B |
| IPO Year | 1999 | 2005 |
| Metric | CRL | HBM |
|---|---|---|
| Price | $161.25 | $24.52 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 3 |
| Target Price | ★ $198.27 | $25.00 |
| AVG Volume (30 Days) | 790.6K | ★ 5.0M |
| Earning Date | 05-07-2026 | 05-01-2026 |
| Dividend Yield | N/A | ★ 0.07% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,857,601,000.00 | N/A |
| Revenue This Year | N/A | $30.66 |
| Revenue Next Year | $3.04 | $14.54 |
| P/E Ratio | ★ N/A | $21.47 |
| Revenue Growth | ★ 10.48 | N/A |
| 52 Week Low | $132.58 | $8.76 |
| 52 Week High | $228.88 | $28.74 |
| Indicator | CRL | HBM |
|---|---|---|
| Relative Strength Index (RSI) | 45.38 | 50.64 |
| Support Level | $147.22 | $23.27 |
| Resistance Level | $166.62 | $28.56 |
| Average True Range (ATR) | 8.97 | 1.17 |
| MACD | -1.18 | -0.13 |
| Stochastic Oscillator | 31.12 | 36.69 |
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Hudbay Minerals Inc is a copper-focused critical minerals company with three long-life operations and a pipeline of copper growth projects in Canada, Peru, and the United States. Its operating portfolio includes the Constancia mine in Cusco (Peru), the Snow Lake operations in Manitoba (Canada), and the Copper Mountain mine in British Columbia (Canada). Copper is the primary metal produced by the company, which is complemented by gold, zinc, silver, and molybdenum production. Hudbay's growth pipeline includes the Copper World project and the Mason project in the USA, and the Llaguen project in Peru. The company's reportable segments are: Peru, which generates the maximum revenue, Manitoba, British Columbia, and Arizona. Geographically, it generates maximum revenue from China and Canada.